Patsner B, Greenberg S
New Jersey Gynecologic Oncology, P.A., Little Silver, New Jersey 07739, USA.
Gynecol Oncol. 1995 Sep;58(3):386-8. doi: 10.1006/gyno.1995.1248.
Four patients with metastatic ovarian mixed Müllerian sarcoma (2 homologous, 2 heterologous) were treated with mesna, doxorubicin, ifosfamide, and dacarbazine (MAID) chemotherapy. Two of four patients had optimal debulking. Three of four patients responded to chemotherapy, with two complete responses of 34- and 46-month duration. The MAID regimen appears to be active in patients with ovarian sarcoma.
4例转移性卵巢混合性苗勒管肉瘤患者（2例同源性，2例异源性）接受了美司钠、多柔比星、异环磷酰胺和达卡巴嗪（MAID）化疗。4例患者中有2例实现了最佳肿瘤细胞减灭术。4例患者中有3例对化疗有反应，其中2例完全缓解，缓解持续时间分别为34个月和46个月。MAID方案似乎对卵巢肉瘤患者有效。
